Skip to main content
SpringerLink
Log in

Bedeutung molekularpathologischer Methoden in der Onkologie

Pathologie und onkologische Entscheidungsprozesse

Relevance of molecular pathological methods in oncology

Pathology and oncological decision processes

  • CME Zertifizierte Fortbildung
  • Published:
Der Onkologe Aims and scope

Zusammenfassung

Die Anzahl von molekularen Untersuchungen in der Histo- und Zytopathologie hat in den letzten Jahren, insbesondere mit zunehmender Bedeutung der sog. personalisierten Medizin bei Krebspatienten, stark zugenommen. Die Ergebnisse dieser Untersuchungen fließen vermehrt in die Pathologieberichte ein, die den behandelnden Ärzten als Grundlage für weitere Therapieentscheidungen dienen. Die wichtigsten molekularen Methoden, die derzeit in der Pathologie eingesetzt werden, werden mit ihren Möglichkeiten und Grenzen vorgestellt.

Abstract

The number of molecular tests used in histopathology and cytopathology has increased dramatically during the last years in particular as a result of the increasing influence of so-called personalized medicine in oncology patients. The results of these tests are becoming increasingly more integrated into pathology reports and serve the treating clinicians as a basis for further therapeutic decisions. The most important molecular methods currently used in pathology are presented including the capabilities and limitations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Moch H, Blank PR, Dietel M et al (2012) Personalized cancer medicine and the future of pathology. Virchows Arch 460:3–8

    Article  PubMed  CAS  Google Scholar 

  2. Stricker T, Catenacci DVT, Seiwert TY (2011) Molecular profiling of cancer – the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic. Semin Oncol 38:173–185

    Article  PubMed  Google Scholar 

  3. Igbokwe A, Lopez-Terrada DH (2011) Molecular testing of solid tumors. Arch Pathol Lab Med 135:67–82

    PubMed  CAS  Google Scholar 

  4. Geyer CE, Forster J, Lindquist D et al (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355:2733–2743

    Article  PubMed  CAS  Google Scholar 

  5. Hortobagyi GN (2005) Trastuzumab in the treatment of breast cancer. N Engl J Med 353:1734–1736

    Article  PubMed  CAS  Google Scholar 

  6. Varga Z, Diebold J, Dommann-Scherrer C et al (2012) How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss working group of breast- and gynecopathologists. PLoS One 7:e37379

    Article  PubMed  CAS  Google Scholar 

  7. Rubin BP, Heinrich MC, Corless CL (2007) Gastrointestinal stromal tumour. Lancet 369:1731–1741

    Article  PubMed  CAS  Google Scholar 

  8. Maemondo M, Inoue A, Kobayashi K et al (2010) Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362:2380–2388

    Article  PubMed  CAS  Google Scholar 

  9. Flaherty KT, Puzanov I, Kim KB et al (2010) Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363:809–819

    Article  PubMed  CAS  Google Scholar 

  10. Jimeno A, Messersmith WA, Hirsch FR et al (2009) KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection. J Clin Oncol 27:1130–1136

    Article  PubMed  CAS  Google Scholar 

  11. Anonymous (2011) Getting personal. Nature 473:253–254

    Google Scholar 

  12. Luciano JS, Andersson B, Batchelor C (2011) The translational medicine ontology and knowledge base: driving personalized medicine by bridging the gap between bench and bedside. J Biomed Semantics 2 [Suppl 2] 2:S1

  13. Dahinden C, Ingold B, Wild P et al (2010) Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res 16:88–98

    Article  PubMed  CAS  Google Scholar 

  14. Jones S, Zhang X, Parsons DW et al (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801–1806

    Article  PubMed  CAS  Google Scholar 

  15. Carracedo A, Ma L, Teruya-Feldstein J et al (2008) Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118:3065–3074

    PubMed  CAS  Google Scholar 

  16. Dietel M, Sers C (2006) Personalized medicine and development of targeted therapies: the upcoming challenge for diagnostic molecular pathology. A review. Virchows Arch 448:744–755

    Article  PubMed  Google Scholar 

  17. Bundesaerztekammer (2010) (Muster-)Weiterbildungsordnung 2003 – Fassung vom 25.06.2010. Bundesaerztekammer, Berlin

  18. Lehr HA, Moch H, Christen B et al (2012) Board examination for anatomical pathology in Switzerland: two intense days to verify professional competence. Virchows Arch 461:87–92

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Institut für Klinische Pathologie, UniversitätsSpital Zürich, Schmelzbergstraße 12, 8091, Zürich, Schweiz

    M. Rössle & H. Moch

Authors
  1. M. Rössle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Moch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Rössle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rössle, M., Moch, H. Bedeutung molekularpathologischer Methoden in der Onkologie. Onkologe 18, 1149–1156 (2012). https://doi.org/10.1007/s00761-012-2362-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-012-2362-3

Schlüsselwörter

Keywords

Search

Navigation